FAKTOR-OPTIONSSCHEIN - COOPER COMPANIES Stock

Certificat

DE000MG33XM5

Market Closed - Bid/Ask 15:45:57 2024-06-27 EDT Pre-market 02:01:18
9.13 EUR -2.25% Intraday chart for FAKTOR-OPTIONSSCHEIN - COOPER COMPANIES 9.275 +1.59%
Current month-13.62%
1 month-15.07%
Date Price Change
24-06-27 9.13 -2.25%
24-06-26 9.34 -1.99%
24-06-25 9.53 -2.06%
24-06-24 9.73 -3.47%
24-06-21 10.08 -0.49%

Delayed Quote Börse Stuttgart

Last update June 27, 2024 at 03:45 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying THE COOPER COMPANIES, INC.
Issuer Morgan Stanley
WKN MG33XM
ISINDE000MG33XM5
Date issued 2024-04-26
Strike 43.99 $
Maturity Unlimited
Parity 4.43 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 11.65
Lowest since issue 9.1
Spread 0.04
Spread %0.43%

Company Profile

The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision and CooperSurgical. CooperVision is engaged in the contact lens industry. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys, Biofinity toric & Biofinity XR toric, Biofinity multifocal, Biofinity toric multifocal, clariti 1 day, clariti 1 day toric, clariti 1 day multifocal, MiSight 1 day, Avaira Vitality and Avaira Vitality toric. CooperSurgical is a fertility and women’s health company dedicated to assisting women, babies and families around the world. CooperSurgical provides a range of products and services with an emphasis on improving fertility solutions, empowering office-based care, and advancing hospital care within women’s health. CooperSurgical’s brands include Paragard, ER-Complete, Fetal Pillow, INSORB, PGT-Complete, RUMI II and others.
Sector
-
More about the company

Ratings for The Cooper Companies, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: The Cooper Companies, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
87.62 USD
Average target price
109.7 USD
Spread / Average Target
+25.22%
Consensus